Press Release

CREATIVE DIAGNOSTICS ANNOUNCES NEW CORONAVIRUS ANIMAL MODEL FOR DRUG DISCOVERY



Creative Diagnostics Announces New Coronavirus Animal Model for Drug Discovery

FOR IMMEDIATE RELEASE

25/11/2024

As an expert in providing solutions to assist virology and microbiology research, Creative Diagnostics is pleased to announce the launch of its innovative Coronavirus Animal Models to accelerate drug discovery and development efforts for the prevention and treatment coronavirus-related diseases. These new models offer researchers a valuable tool for studying the pathogenesis of the virus, testing potential therapeutic agents, and evaluating vaccine efficacy.

Coronaviruses (CoV) are enveloped, positive, single-stranded RNA viruses that infect humans, monkeys, mice, pigs, cats, dogs, wolves, chickens, cattle and avian vertebrates. The virus enters host cells through the interaction of a spike protein on the viral capsid with a cell surface receptor. However, coronaviruses have crossed the species barrier and caused three serious human respiratory infections in the past 17 years. These include the severe acute respiratory syndrome coronavirus (SARS-CoV) in 2003, the Middle East respiratory syndrome coronavirus (MERS-CoV) in 2012, and a novel outbreak of coronavirus infection in Wuhan in 2019 (CoVID-2019).

These outbreaks have resulted in severe disease and high mortality, but there is still a lack of effective vaccines and antivirals against coronaviruses. Therefore, there is an urgent need for in-depth studies of the pathogenesis of coronaviruses in animals and for the evaluation of the efficacy and safety of potential vaccines and antiviral therapies.

Although many animal models are available, none fully recapitulates the entire process of human coronavirus infection. Creative Diagnostics is committed to providing innovative solutions for coronavirus research, including the development and use of animal models. These coronavirus animal models offered by Creative Diagnostics include SARS-CoV Virus Intranasal Infection Rhesus Monkey Models, SARS-CoV Virus Intranasal Infection Mouse Models, and SARS-CoV-2 Syrian Hamster Models. These models are invaluable for evaluating pathogenicity, transmissibility, severe pathogenesis mechanisms, and virus-host immune interactions.

In addition, Creative Diagnostics offers a comprehensive range of services to support Coronavirus animal model studies for various aspects of human Coronavirus infection. These services include study design, pathological analysis, immune response profiling, efficacy testing, and data analysis. With extensive industry experience, the Creative Diagnostics research team understands the strengths and weaknesses of each animal model and tailors the models to meet the scientific goals of the researcher.

By providing researchers with reliable and relevant models, Creative Diagnostics hopes to contribute to the development of effective countermeasures against coronavirus infections. The company’s expertise in animal modeling and virology ensures that researchers have access to high-quality tools and support for their research endeavors. These models provide a robust and reliable platform for researchers to advance their understanding of coronavirus infections and develop novel countermeasures.

Creative Diagnostics is dedicated to accelerating the progress of its global customers’ projects and specializes in the development of animal models for coronavirus infection. To find out more about these new animal models and other products from Creative Diagnostics, please visit https://antiviral.creative-diagnostics.com/coronavirus-animal-model.html.

About Creative Diagnostics

Headquartered in New York, Creative Diagnostics is a consulting and experimental service provider specializing in virology and microbiology. The company provides comprehensive solutions to conquer obstacles in virology and microbiology research, from high-security infrastructure provision, biosafety regulation elucidation, to expert viral system assistance.

Tags:
Coronavirus Animal Model  |  Creative Diagnostics  |  

---

Organisation Profile:
Creative Diagnostics is a leading manufacturer and supplier of antibodies, viral antigens, innovative diagnostic components, and critical assay reagents. We provide contract biologic R&D and manufacturing services to the diagnostic manufacturers along with GMP biologics manufacturing for the biopharmaceutical market. Our goal is to be a trusted source for all your assay development and manufacturing needs.






Press release contact details for Creative Diagnostics

NameCreative Diagnostics
Tel
Fax
Email
Websitehttps://www.creative-diagnostics.com/
OrganisationCreative Diagnostics
Address
Town
County0
Postcode11967




Other press releases from Creative Diagnostics

Creative Diagnostics Launches HPV L1 Antibodies for Neutralization and Vaccine Development
Creative Diagnostics Introduces TCID50 Assay Service for Determining Viral Titers
Creative Diagnostics Introduces ELISA Kit Development Services to Support IVD Research
Creative Diagnostics Introduces Microneutralization Assay Service for Virus Detection
Creative Diagnostics Introduces Virus Yield Reduction Assay Service
Creative Diagnostics Introduces New Low Endotoxin Antibodies for Researchers
Creative Diagnostics Announces Calprotectin Reagents for Inflammatory Disease Research
Creative Diagnostics Introduces Viral Replicon Assay Service to Support Virology Research
Creative Diagnostics Announces the Launch of Radial Immunodiffusion Testing Service
Creative Diagnostics Launches Highly Specific Antibodies Against FXIIIa/F13A1 for Vascular Diseases
Creative Diagnostics Introduces qPCR Assay for Rapid Virus Detection and Quantification
Creative Diagnostics Launches New Reagent Solutions for Herpesvirus Research
Creative Diagnostics Announces New Reagents for Bioanalysis of Antibody Drug Conjugates
Creative Diagnostics Announces New Antimicrobial Susceptibility Testing Services
Creative Diagnostics Introduces New ELISA Kits to Accelerate Autoimmunity Research
Creative Diagnostics Launches Antimicrobial Synergy Testing Services
Creative Diagnostics Launches New Azaperone Test Reagents for Research Applications
Creative Diagnostics Launches Checkerboard Assay Services
Creative Diagnostics Launches New Anti-Small Molecule Label Antibodies to Facilitate NALFIA Development
Creative Diagnostics Announces New CLDN6 Solutions for Cancer Research
Creative Diagnostics Launches Minimum Inhibitory Concentration Testing Services
Creative Diagnostics Launches Carbamazepine Test Reagents
Creative Diagnostics Launches Macrophage Migration Inhibitory Factor Reagents for Research Applications
Creative Diagnostics Announces New Test Reagents for Dapsone
Creative Diagnostics Announces New MBC Assay for Antibacterial Testing Read more: https://www.digitaljournal.com/pr/news/getnews/creative-diagnostics-announces-new-mbc-assay-for-antibacterial-testing#ixzz8KcL65cji
Creative Diagnostics Announces New MBC Assay for Antibacterial Testing
Creative Diagnostics Launches Rapid Robenidine Test Reagents for the Analysis of Anticoccidial Residues
Creative Diagnostics Announces MDT Services for Measuring Antibacterial Effectiveness
Creative Diagnostics Launches New P53 and TP53 Antibodies for Cancer Research
Creative Diagnostics Launches Aflatoxin Test Reagents to Ensure Food Safety
Creative Diagnostics Launches Serum Plate Agglutination Test for In Vitro Detection of Multiple Pathogens
Creative Diagnostics Announces New AAV Reagent Solutions for Gene Therapy
Citrinin Test Reagents for Food Safety
Creative Diagnostics Announces Novel Agar Gel Precipitin Tests for Viral Antigen Detection
Creative Diagnostics Introduces Cutting-Edge Anti-AAV Antibody ELISA Kits for Gene Therapy Research
Creative Diagnostics Announces the Launch of Its Highly Sensitive Kanamycin ELISA Kit for Precise Antibiotic Detection
Creative Diagnostics Launches Comprehensive ELISA Based Assays for Vaccine Development
Creative Diagnostics Announces Comprehensive Vomitoxin Test Reagents for Food Safety Applications
High-Affinity Anti Venom Antibodies for Research Applications
Creative Diagnostics Introduces Immunofluorescence Assay Testing Services for Virology Research
Creative Diagnostics Launches Comprehensive Fumonisin Test Reagents for Precise Food Safety Analysis
Creative Diagnostics Introduces Comprehensive Range of Ochratoxin Test Reagents for Enhanced Food Safety Analysis
Creative Diagnostics Launches Plaque Reduction Assay Services to Advance Antiviral Research
Creative Diagnostics Announces the Launch of Norovirus VLP Antigens to Support Vaccine Research
Creative Diagnostics Introduces Patulin Test Reagents for Food Safety Applications
Creative Diagnostics Launches Reliable Hemagglutination Assay for Virus and Antibody Detection
Creative Diagnostics Announces High-Affinity Anti-Adenovirus Monoclonal Antibodies for Research and Assay Development
Animal-Derived DNA Residue Assay Kits (qPCR) for Research Applications
Creative Diagnostics Introduces Alternariol Test Reagents for Food Safety Detection
Creative Diagnostics Announces New Coronavirus Animal Model for Drug Discovery
Creative Diagnostics Introduces New Anti-RBC Antibodies for Enhanced Blood Product Purity and Autoimmune Disease Research

Disclaimer:
Issuers of the press releases are solely responsible for the content of their press releases. Connect2business.co.uk cannot be held liable for the content posted by others to this website.